CKD Flashcards
Thiazide diuretics and CKD
Limited utility in stages 3 to 5 so that administration of loop diuretics may be needed
Combination of loop diuretics with this may be helpful
Metolazone
Indication to start dialysis in relation to diuretic use
Diuretic resistance with intractable edema and hypertension
Cause of acute-on-chronic kidney disease
Hypoperfusion
Predominant method of potassium excretion in the kidney
Aldosterone-dependent secretion in the distal nephron
Medications that inhibit potassium secretion
RAS inhibitors, spironolactone, amiloride, eplerenone and triamterene
Renal diseases that affect the distal nephron that cause hyperkalemia
Obstructive uropathy
Sickle cell nephropathy
Hypokalemia in CKD
Rare and usually associated with poor oral intake
CKD patients produce less of this causing metabolic acidosis
Ammonia
Electrolyte abnormality that impairs ammonia excretion
Hyperkalemia
This combination is present in patients with early stages of CKD, those with DM nephropathy and those with TIN or obstructive uropathy
Hyperkalemia with hyperchloremic metabolic acidosis
Anion gap in early and late CKD
NAGMA in early
HAGMA in late (due to retention of anions)
Recommendation for alkali supplementation
When bicarbonate falls below 20 - 23 mmol/L
Indication for water restriction in CKD
Hyponatremia
Potassium-binding resins
Calcium resonium
Sodium polystyrene
Patiromer
Mild degrees of metabolic acidosis can cause
Protein catabolism
Classic lesion of secondary hyperparathyroidism
Osteitis fibrosa cystica
High bone turnover with high PTH
Osteitis fibrosa cystica
Lower bone turnover with low or normal PTH
adynamic bone disease
GFR level below which phosphate retention occurs starting the chain of events
60
Class of FGF-23
Phosphatonins
FGF-23 secreted by
Osteocytes
Ways FGF-23 maintains normal serum phosphorus
- Increased renal phosphate excretion
- Stimulation of PTH
- Suppression of formation of activated Vitamin D, leading to diminished absorption in GI tract
High levels of FGF 23 is risk factor for
LVH and mortality
Histology is osteitis fibrosa cystica
Abnormal osteoid, bone and bone marrow fibrosis and formation of bone cysts with hemorrhagic elements
Considered a uremic toxin
PTH
Population at risk for adynamic bone disease
Elderly and diabetics
Causes of adynamic bone disease
- Excessive suppression of PTH production
2. Chronic inflammation